Growth Metrics

Acadia Pharmaceuticals (ACAD) Cash from Investing Activities (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 218.64%
Dec 31, 2025 29.59%
Sep 30, 2025 -83.29%
Jun 30, 2025 65.10%
Mar 31, 2025 -201.55%
Dec 31, 2024 248.14%
Sep 30, 2024 -46.74%
Jun 30, 2024 -300.26%
Mar 31, 2024 -3,945.82%
Dec 31, 2023 -101.02%
Sep 30, 2023 117.56%
Jun 30, 2023 -200.92%
Mar 31, 2023 1,184.73%
Dec 31, 2022 -214.94%
Sep 30, 2022 127.67%
Jun 30, 2022 -142.48%
Mar 31, 2022 83.57%
Dec 31, 2021 145.77%
Sep 30, 2021 -808.47%
Jun 30, 2021 -155.73%
Mar 31, 2021 126.40%
Dec 31, 2020 -176.45%
Sep 30, 2020 20.60%
Jun 30, 2020 328.48%
Mar 31, 2020 114.16%
Dec 31, 2019 -2,207.67%
Sep 30, 2019 -6.62%
Jun 30, 2019 -53.30%
Mar 31, 2019 112.04%
Dec 31, 2018 -694.48%
Sep 30, 2018 906.29%
Jun 30, 2018 -104.40%
Mar 31, 2018 595.32%
Dec 31, 2017 -193.59%
Sep 30, 2017 -49.52%
Jun 30, 2017 -27.65%
Mar 31, 2017 -23.44%
Dec 31, 2016 144.63%
Sep 30, 2016 -1,976.51%
Jun 30, 2016 95.58%
Mar 31, 2016 -397.39%
Dec 31, 2015 582.78%
Sep 30, 2015 -81.15%
Jun 30, 2015 14.53%
Mar 31, 2015 -4.95%
Dec 31, 2014 4.12%
Sep 30, 2014 157.58%
Jun 30, 2014 31.89%
Mar 31, 2014 -1,138.80%
Dec 31, 2013 341.97%
Sep 30, 2013 96.00%
Jun 30, 2013 -198.06%
Mar 31, 2013 5.61%
Dec 31, 2012 -1,177.48%
Sep 30, 2012 -132.69%
Jun 30, 2012 116.48%
Mar 31, 2012 1.63%
Dec 31, 2011 -14.81%
Sep 30, 2011 -30.27%
Jun 30, 2011 173.52%
Mar 31, 2011 -12.55%
Dec 31, 2010 -363.71%